However, subsequent larger-scale trials produced inconsistent results
[12] In July 2022, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending granting a marketing authorization for the medicinal product Mounjaro, intended for the treatment of type 2 diabetes
This hormone is the primary driver of muscle cell hyperplasiathe creation of new muscle fibers
Tumor incidence dependence on Epitalon administration and light exposure was also investigated in female LIO rats
These issues primarily stem from poor bioavailability, variability in extraction and quantification methods, uncertainties regarding long-term safety, and a lack of robust clinical evidence from human trials
Journal of cellular and molecular medicine